Question 1

What did the FDA authorize Johnson & Johnson to sell?

Accepted Answer

The FDA granted De Novo marketing authorization for the OTTAVA Robotic Surgical System, cleared for ten general surgery procedures in the upper abdomen, including cholecystectomy, appendectomy, gastric sleeve, and Roux-en-Y gastric bypass.

Question 2

What makes OTTAVA different from other surgical robots?

Accepted Answer

According to Johnson & Johnson, OTTAVA integrates its four robotic arms directly into the operating table rather than using carts or booms, a design the company says occupies 30 to 50 percent less space than traditional systems.

Question 3

When will hospitals be able to use OTTAVA?

Accepted Answer

Johnson & Johnson said it will launch the system commercially with select US customers first, while pursuing additional approved uses and clearance in other countries; a US clinical trial for inguinal hernia repair is ongoing.

Johnson & Johnson

Johnson & Johnson wins FDA authorization for its robotic surgery device

One sharp brief.
Every day.

Johnson & Johnson

Johnson & Johnson wins FDA authorization for its robotic surgery device

One sharp brief.Every day.

One sharp brief.
Every day.